Dr. Reddy's Labs Files 6-K, Confirms 20-F Filing

Ticker: RDY · Form: 6-K · Filed: Jun 30, 2025 · CIK: 1135951

Sentiment: neutral

Topics: sec-filing, foreign-private-issuer, administrative

TL;DR

DRL filed a 6-K, confirming it's a foreign private issuer and will file 20-F. Standard procedure.

AI Summary

Dr. Reddy's Laboratories Limited filed a Form 6-K on June 30, 2025, indicating it is a foreign private issuer and will file annual reports under Form 20-F. The filing provides basic company information, including its address in Hyderabad, Telangana, India, and its principal executive office phone number.

Why It Matters

This filing is a routine disclosure for foreign private issuers, confirming their reporting status and providing essential contact and identification information to the SEC.

Risk Assessment

Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain new financial or operational information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer would be required to make public pursuant to the laws of its home country, or to file with its home country's stock exchange, or to distribute to its security holders.

What does it mean that Dr. Reddy's Laboratories Limited is a 'foreign private issuer'?

A foreign private issuer is a foreign entity that is not owned by a U.S. person for more than 50 percent of its voting power or more than 50 percent of its assets, and does not have its majority of executive officers or directors as U.S. citizens or residents.

What is Form 20-F?

Form 20-F is the annual report required to be filed by foreign private issuers with the U.S. Securities and Exchange Commission (SEC).

When was this Form 6-K filed?

This Form 6-K was filed on June 30, 2025.

Where is Dr. Reddy's Laboratories Limited's principal executive office located?

Dr. Reddy's Laboratories Limited's principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on June 30, 2025 regarding DR REDDYS LABORATORIES LTD (RDY).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing